In order to give users the ability to close the loop on the medication use process and quickly spot anomalous activity in real time, RxAuditor Reconcile, a new addition to the company’s extensive product portfolio, was developed by Medacist, the industry leader in drug diversion technology solutions.
RxAuditor Reconcile helps RxAuditor Investigate by providing healthcare practitioners with actionable data to ease and expedite medication diversion investigations. It is based on the company’s 24 years of industry-specific data. The drug analytics solution, which is supported by Medacist’s GenesisTM platform, uses artificial intelligence and machine learning to give businesses standardised, collaborative workflows for drug diversion efforts.
According to David J. Brzozowski Jr., CTO at Medacist, “RxAuditor Reconcile from Medacist gives a simpler, faster, and more cost-effective solution for accountability in healthcare institutions.” By monitoring the full chain of custody for all drugs, the inclusion of this new product to our portfolio gives our customers access to a strong drug diversion detection solution that improves medication observability.

Source: Prnewswire